iBIONICS Attracts Leading Bionic Scientist, Professor Jim Patrick, to Post of Advisory Board Chair
The iBIONICS Diamond Eye team is delighted to announce that Professor Jim Patrick of cochlear implant fame has joined as Chair of the iBIONICS Advisory Board. Professor Patrick was part of the early development team of the cochlear implant, and has been a key member of the team that has seen Cochlear Limited grow to a company that has supplied implants to over 300,000 hearing impaired people worldwide.
Ontario Bioscience Innovation Organization Provides Opportunity for iBIONICS to Access Investment
iBIONICS and their groundbreaking Diamond Eye project continue to gather accolades and honours. Most recently, iBIONICS was selected as one of 10 high potential early stage bioscience startup companies to participate in the 2017 Capital Access Advisory Program (CAAP®) of Ontario Bioscience Innovation Organization (OBIO). Selection into this program, now in its 5th year, is further evidence that the iBIONICS’ effort to restore partial sight is one of the bright lights in Ontario’s bioscience startup community.
Ottawa, Canada, November 29, 2016 - After being given top provincial honours, iBIONICS has now won Startup Canada’s National Innovation Award for their work in developing a solution for blindness. Startup Canada Innovation Award is awarded to a Canadian company exhibiting excellence in innovation through leveraging new knowledge or technology in solving real world problems. The annual Startup Canada Awards are the hallmark event that celebrate and recognize those driving impact and demonstrating excellence in Canada’s entrepreneurship and innovation community.
Harvard University, Department of Physics, Jefferson Laboratory 250 17 Oxford Street, Cambridge, Massachusetts
Professor Steven Prawer, Cofounder and CTO of iBIONICS, lead inventor of the Diamond Eye and Scientific Advisor to Stentrode (as explained by President Obama on the Science Channel) provides a glimpse into the future. A future where implants, bionics, and human-machine interfaces will become the new normal.
Melbourne, Australia, November 9, 2016 - Researchers from the Department of Physics at the University of Melbourne (Dr David Garrett and Professor Steven Prawer) and the National Vision Research Institute (NVRI) of Australia founded by the Australian College of Optometry (Professor Michael Ibbotson and Associate Professor Hamish Meffin) have won a $1 M dollar grant from the National Health and Medical Research Council (NHMRC). The grant will be used to help demonstrate that their next generation diamond retinal implant can dramatically improve the quality of vision experienced by bionic eye users.
Ottawa, Canada, October 4, 2016 - iBIONICS has won Startup Canada’s Innovation Award 2016 in the Quebec Regionfor their work towards finding a solution for blindness. Startup Canada’s Innovation Award is given to a Canadian company exhibiting excellence in innovation, in any sector, through leveraging new knowledge or technology to solve real world problems.
The Diamond Eye Project has Exciting New Collaboration with University of Ottawa
Ottawa, Canada, August 23, 2016 - iBIONICS has announced that they have chosen the SUNLAB, part of the Centre for Research in Photonics at the University of Ottawa, one of the foremost photonics centres in the world, for collaboration in developing the wireless capability to transfer data and power for their Diamond Eye solution to blindness. This will be accomplished with the development of a high efficiency photovoltaic (PV) cell.
Diamond Eye Startup Selected as Favourite for Technology Entrepreneurship Project
Ottawa, Canada, August 22, 2016 - iBIONICS competed with Ottawa’s top startups and has won at the School Your Startup Pitchfest. This marks the beginning of an important relationship between the emerging medical device company and a team of six Executive MBA consultants, who selected iBIONICS’ Diamond Eye for their technology entrepreneurship project.
As a new startup, iBIONICS is not only pioneering new technology, but is very focused on collaboration and team work, the key to success. We pride ourselves on the way our team functions and works together to ensure the quality of our work is of a world-class standard.
We would like share how the technology of iBIONICS came to be and how our team was brought together from across the globe through the lens of individuals that comprise our team.
While our legs are sore, we want to take a moment to reflect on Cycle for Sight Ottawa 2016. We connected with some amazing people with inspiring stories and raised some much-needed funds and awareness for debilitating eye diseases. So far, iBIONICS has managed to raise $1,560 and the Cycle for Sight Ottawa fundraiser has managed to surpass its goal of $60,000.
iBIONICS is a born global health innovation startup with headquarters in Ottawa Canada and operations in Melbourne Australia, and Montreal Quebec. iBIONICS delivers health solutions by designing, manufacturing and commercializing implantable bionic solutions that treat debilitating diseases.